SALMONELL A ENTERICA AND CYTOKINE SYSTEM OF THE HOST


Cite item

Full Text

Abstract

Contemporary data on mechanisms of immune defense during salmonellosis as well as on ability of Salmonella to resist these mechanisms are presented in the review. Main emphasis is made on reaction of cytokine system of innate and adaptive immunity described in experimental and clinical studies.

Full Text

SALMONELLA ENTERICA И СИСТЕМА ЦИТОКИНОВ ХОЗЯИНА
×

About the authors

G. F Zheleznikova

Research Institute of Pediatric Infections, SaintPetersburg, Russia

O. A Volokhova

Research Institute of Pediatric Infections, SaintPetersburg, Russia

References

  1. Железникова Г.Ф. Роль гамма-интерферона в иммунопатогенезе инфекций. Клин. лаб. диагн. 2008, 4: 3-8.
  2. Кетлинский С.А., Симбирцев А.С. Цитокины. СПб, Фолиант, 2008.
  3. Мартынова Н.Н., Аленов М.Н., Пак С.Г., Умбетова К. Динамика содержания цитокинов и газового состава крови больных сальмонеллезом и острым шигеллезом. Тер. архив. 2006, 78 (11): 24-27.
  4. Поздеев О.К., Федоров Р.В. Энтеробактерии. М., Гэотар-Медиа, 2007.
  5. Романова Ю.М., Щегловитова О.Н., Бошнаков Р.К. и др. Активация размножения Salmonella typhimurium в органах зараженных животных при действии ФНО-α и острого γ-облучения. Rus. J. Immunol. 2002, 7 (2): 129-134.
  6. Bao S., Beagley K., France M. et al. Interferongamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunol. 2000, 99 (3): 464-472.
  7. Berin M., Dwinell M., Eckmann L., Kagnoff M. Production of MDC/CCL22 by human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280 (6): G217-226.
  8. Berntman E., Rolf J., Johansson C. et al. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur. J. Immunol. 2005, 35 (7): 2100-2109.
  9. Bueno S., González P., Schwebach J., Kalergis A. T cell immunity evasion by virulent Salmonella enterica. Immunol. Lett. 2007, 111 (1): 14-20.
  10. Cook P., Tötemeyer S., Stevenson C. et al. Salmonella-induced SipB-independent cell death requires Toll-like receptor-4 signalling via the adapter proteins Tram and Trif. Immunol. 2007, 122 (2): 222-229.
  11. Depaolo R., Lathan R., Rollins B., Karpus W. The chemokine CCL2 is required for control of murine gastric Salmonella enterica infection. Infect. Immun. 2005, 73 (10): 6514-6522.
  12. Dharmana E., Keuter M., Netea M. et al. Divergent effects of TNF-α and lymphotoxin-α on lethal endotoxemia and infection with live Salmonella typhimurium in mice. Eur. Cytokine Netw. 2002, 13 (1): 104-109.
  13. Diepen van A., Martina C., Flierman R. et al. Treatment with anti-TNF-α does not induce reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. Scand. J. Immunol. 2007, 65 (5): 407-411.
  14. Eckmann L., Kagnoff M. Cytokines in host defense against Salmonella. Microbes Infect. 2001, 3 (14-15): 1191-1200.
  15. Elhofy A., Marriott I., Bost K. Salmonella infection does not increase expression and activity of the high affinity IL-12 receptor. J. Immunol. 2000, 165 (6): 3324-3332.
  16. Fahy O., Townley S., Coates N. et al. Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3α/CCL20. Lab. Invest. 2004, 84 (11): 1501-1511.
  17. Fahy O., Townley S., McColl S. CXC16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gammainterferon production. Infect. Immun. 2006, 74 (12): 6885-6894.
  18. Fieschi C., Casanova J. The role of IL-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. 2003, 33 (6): 1461-1464.
  19. Gajendran N., Mittrücker H., Bordasch K. et al. Regional IFN-γ expression is insufficient for efficacious control of food-borne bacterial pathogens at the gut epithelial barrier. Int. Immunol. 2007, 19 (9): 1075-1081.
  20. Galdiero M., Marcatili A., Cipollaro de l’Ero G. et al. Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice. Infect. Immun. 1999, 67 (3): 1432-1438.
  21. Gerlach R., Hensel M. Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica. Berl. Munch. Tierarztl. Wochenschr. 2007, 120 (7-8): 317-327.
  22. Godinez I., Rafatellu M., Chu H. et al. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect. Immun. 2009, 77 (1): 387-398.
  23. Harrington L., Srikanth C., Antony R. et al. A role for natural killer cells in intestinal inflammation caused by infection with Salmonella enterica serovar Typhimurium. FEMS Immunol. Med. Microbiol. 2007, 51 (2): 372-380.
  24. Izadpanah A., Dwinell M., Eckmann L. et al. Regulated MIP-3α/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280 (4): G710-719.
  25. John B., Rajagopal D., Pashine A. et al. Role of IL-12-independent pathways in regulating generation of IFN-γ component of T cell responses to Salmonella typhimurium. J. Immunol. 2002, 169 (5): 2545-2552.
  26. Kirby A., Yrlid U., Wick M. The innate immune response differs in primary and secondary Salmonella infection. Ibid. 2002, 169 (8): 4450-4459.
  27. Koebernick H., Grode L., David J. et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA. 2002, 99 (21): 13681-13686.
  28. Layton A., Galyov E. Salmonella-induced enteritis: molecular pathogenesis and therapeutic implications. Expert. Rev. Mol. Med. 2007, 9 (18): 1-17.
  29. Lehmann J., Bellmann S., Werner C. et al. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol. 2001, 167 (9): 5304-5315.
  30. Lin A., Lin C., Chen C., Chen W. Host defense against Salmonella and rotaviral gastroenteritis: a serial study of transcriptional factors and cytokines. J. Microbiol. Immunol. Infect. 2008, 41 (3): 265-271.
  31. Maaser C., Eckmann L., Paesold G. et al. Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. Gastroenterology. 2002, 122 (3): 667-680.
  32. MacLennan C., Fieschi C., Lammas D. et al. IL-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 2004, 190 (10): 1755-1757.
  33. Mastroeni P. Immunity to systemic Salmonella infection. Curr. Mol. Med. 2002, 2 (4): 393-406.
  34. Mittrücker H., Köhler A., Kaufmann S. Charac- terization of the murine T-lymphocyte response to Salmonella enterica serovar Typhimurium infection. Infect. Immun. 2002, 70 (1): 199-203.
  35. Mizuno Y., Takada H., Nomura A. et al. Th1- and Th2-inducing cytokines in Salmonella infection. Clin. Exp. Immunol. 2003, 131 (1): 111-117.
  36. Monack D., Navarre W., Falkow S. Salmonellainduced macrophage death: the role of caspase-1 in death and inflammation. Microbes Infect. 2001, 3 (14-15): 1201-1212.
  37. Monack D., Bouley D., Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nrampl1+/+ mice and can be reactivated by IFN-γ neutralization. J. Exp. Med. 2004, 199 (2): 231-241.
  38. Naiki Y., Nishimura H., Itohara S., Yoshikai Y. γδ T cells may dichotomously modulate infection with avirulent Salmonella choleraesuis via IFN-γ and IL-13 in mice. Cell. Immunol. 2000, 202 (1): 61-69.
  39. Netea M., Fantuzzi G., Kullberg B. et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J. Immunol. 2000, 164 (5): 2644-2649.
  40. Ottenhoff T., Verreck F., Lichtenauer-Kaligis E. et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 2002, 32 (1): 97-105.
  41. Pascual D. The protective role of IL-18 in Salmonella infection. Curr. Opin. Infect. Dis. 2001, 14 (3): 265-271.
  42. Pietilä T., Veckman V., Kyllönen P. et al. Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J. Leukoc. Biol. 2005, 78 (4): 909-920.
  43. Price J., Simpendorfer K., Mantena R. et al. Gamma-IFN-independent effects of IL-12 on immunity to Salmonella enterica serovar Typhimurium. Infect. Immun. 2007, 75 (12): 5753-5762.
  44. Raupach B., Peuschel S., Monack D., Zychlinsky A. Caspase-1-mediated activation of IL-1β and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Ibid. 2006, 74 (8): 4922- 4926.
  45. Sashinami H., Yamamoto T., Nakane A. The cytokine balance in the maintenance of a persistent infection with Salmonella enterica serovar Typhimurium in mice. Cytokine. 2006, 33 (4): 212-218.
  46. Sebastiani G., Blais V., Sancho V. et al. Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strains. Infect. Immun. 2002, 70 (4): 1997- 2009.
  47. Srinivasan A., Salazar-González R., Jarcho M. et al. Innate immune activation of CD4 T cells in salmonella-infected mice is dependent on IL-18. J. Immunol. 2007, 178 (10): 6342-6349.
  48. Stoycheva M., Murdjeva M. Serum levels of IFN-γ, IL-12, TNF-α, and IL-10, and bacterial clearance in patients with gastroenteric Salmonella infection. Scand. J. Infect. Dis. 2005, 37 (1): 11-14.
  49. Sundquist M., Rydström A., Wick M. Immunity to Salmonella from a dendritic point of view. Cell. Microbiol. 2004, 6 (1): 1-11.
  50. Wick M. Living in the danger zone: innate immunity to Salmonella. Curr. Opin. Microbiol. 2004, 7 (1): 51-57.
  51. Wick M. Monocyte and dendritic cell recruitment and activation during oral Salmonella infection. Immunol. Lett. 2007, 112 (2): 68-74.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Zheleznikova G.F., Volokhova O.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies